# FDA Inspection 668020 - EBI, LLC - June 18, 2010

Source: https://www.keypedia.com/records/fda_inspections/ebi-llc/e23881f8-6161-4a00-9d6d-945b749bad5b
Source feed: FDA_Inspections

> FDA Inspection 668020 for EBI, LLC on June 18, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 668020
- Company Name: EBI, LLC
- Inspection Date: 2010-06-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1209800 - 2023-06-28](https://www.keypedia.com/records/fda_inspections/ebi-llc/f4ad8ce0-81dc-4984-bbeb-cd0d8f88654b)
- [FDA Inspection 1119274 - 2020-01-08](https://www.keypedia.com/records/fda_inspections/ebi-llc/515660bb-ecd1-4ea9-b30d-6b9320af6e8c)
- [FDA Inspection 1119274 - 2020-01-08](https://www.keypedia.com/records/fda_inspections/ebi-llc/2cd40c23-4585-4f6e-96da-fd7480a4fc4b)
- [FDA Inspection 876104 - 2014-04-24](https://www.keypedia.com/records/fda_inspections/ebi-llc/b3829fe1-c750-470a-9af5-c9176f7ee428)

Company: https://www.keypedia.com/companies/ebi-llc/3fec1933-0096-4254-8d92-4c6d3ebe161a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d